Advertisement

The Indian Journal of Pediatrics

, Volume 85, Issue 10, pp 830–831 | Cite as

Ventilator Associated Pneumonia in Children: Current Status and Future Prospects

  • Virendra Kumar
Editorial Commentary
  • 87 Downloads

Invasive mechanical ventilation (MV) is a lifesaving support system for critically sick children in emergency and Intensive care units. As per the national estimates, there were 790,257 hospitalizations with MV across all ages (except newborns) in the United States in 2005. This accounted for 2.7 episodes of mechanical ventilation per 1000 population and an estimated cost of $27.0 billion [1]. Though MV is now used even at district level hospitals, no such estimates are available for most of the developing countries, which makes it difficult to assess the true burden of VAP. Though the reported incidence across the globe varies from 2 to 17%, a higher incidence of 38.4% is reported from the developing countries [2].

In this issue of the journal, an article by Gnanaguru et al. from Northern India evaluated the incidence, risk factors and etiological agents for VAP in children. They used CDC criteria to diagnose VAP, primarily for the uniformity and comparison of incidence with other...

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    Wunsch H, Linde-Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation in the United States. Crit Care Med. 2010;38:1947–53.CrossRefPubMedGoogle Scholar
  2. 2.
    Vijay G, Mandal A, Sankar J, Kapil A, Lodha R, Kabra SK. Ventilator associated pneumonia in pediatric intensive care unit: incidence, risk factors and etiological agents. Indian J Pediatr. 2018;  https://doi.org/10.1007/s12098-018-2662-8.
  3. 3.
    Galal YS, Youssef RML, Ibrahiem SK. Ventilator-associated pneumonia: incidence, risk factors and outcome in paediatric intensive care units at Cairo university hospital. J Clin Diagn Res. 2016;10:SC06–11.Google Scholar
  4. 4.
    Gupta A, Kapil A, Kabra SK, et al. Assessing the impact of an educational intervention on ventilator associated pneumonia in a pediatric critical care unit. Am J Infect Control. 2014;42:111–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Chang I, Schibler A. Ventilator associated pneumonia in children. Paediatr Resp Rev. 2016;20:10–6.Google Scholar
  6. 6.
    Isguder R, Ceylan G, Agin H, et al. New parameters for childhood ventilator associated pneumonia diagnosis. Pediatr Pulmonol. 2017;52:119–28.CrossRefPubMedGoogle Scholar
  7. 7.
    Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol. 2011;11:330–42.CrossRefPubMedGoogle Scholar
  8. 8.
    Shindo Y, Fuchs AG, Devis CG, et al. Interleukin 7 immunotherapy improves host immunity and survival in a two hit model of Pseudomonas aeruginosa pneumonia. J Leukoc Biol. 2017;101:543–54.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of PediatricsLady Hardinge Medical CollegeNew DelhiIndia

Personalised recommendations